About Us
Product Pipeline
Investors
Resources
News & Media
Contact Us
DARA News
Quick Links
Board of Directors
Management Team
Product Pipeline
Soltamox®
Bionect®
Media Contact
Contact Us
Investor Toolkit
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
News & Events
News (Press Releases)
Events
Media
Media Contacts
Media Resources
Media Kit Request
Presentations
2013 News Releases
Keyword Search
2013 |
2012
|
2011
|
2010
|
2009
Date
Title
05/15/13
DARA Reports First Quarter 2013 Financial Results and Operational Highlights
04/22/13
DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis
04/03/13
DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy
04/01/13
DARA Reports Year-End 2012 Financial Results
03/18/13
DARA BioSciences to Present at 25th Annual Roth Conference
03/05/13
DARA BioSciences Appoints Haywood Cochrane Jr. as Chairman of the Board of Directors and Names Paul Richardson as a New Board Member
02/14/13
DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule
02/11/13
DARA BioSciences to Present at 15th Annual BIO CEO & Investor Conference
01/08/13
DARA BioSciences to Present at the 6th Annual OneMedForum Conference
